Search Results - subject:"fixed-dose combination"

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

Homar, Franc; Lozano, Virginia; Marínez-Gómez, Juan; … - In: Health Economics Review 2 (2012) 16, pp. 1-9

Background: The lower sales price of generic lamivudine has caused healthcare administrators to consider abolishing fixed-dose antiretroviral combinations (FDCs) that contain lamivudine and emtricitabine. The alternative is to administer the individual components of the FDCs separately, thus...

Persistent link: https://www.econbiz.de/10010317150

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

Homar, Francesc; Lozano, Virginia; Martínez-Gómez, Juan; … - In: Health Economics Review 2 (2012) 1, pp. 1-9

Our study suggests that the discontinuation of FDC treatment and the replacement with the administration of separate antiretroviral agents could lead to an increase in healthcare costs due to the higher rate of adverse events that was observed with the discontinuation of FDCs. </AbstractSection> Copyright Homar...

Persistent link: https://www.econbiz.de/10010998789

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

Homar, Franc; Lozano, Virginia; Marínez-Gómez, Juan; … - In: Health economics review 2 (2012) 16, pp. 1-9

Persistent link: https://www.econbiz.de/10009752877